In support and extension of this finding, it was shown that POLR3G inhibition resulted in prostate cancer cell-specific proliferation arrest and cell death [17] and that POLR3G overexpression correlated with bad prognosis of transitional cell carcinoma [18]. The gene discussed is POLR3G; the disease is prostate carcinoma.